Engineered Liposomes for Potential α-Particle Therapy of Metastatic Cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  The Journal of Nuclear Medicine

• Publication date

  2004-02-01

• Fields of study

  Medicine, Chemistry, Engineering

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts

  2003cited by this paper
• Actinium-225 Conjugates of MAb CC49 and Humanized ΔCH2CC49

  2002cited by this paper
• The effect of metal cations on the phase behavior and hydration characteristics of phospholipid membranes.

  2002cited by this paper
• Targeted α particle immunotherapy for myeloid leukemia

  2002cited by this paper
• Targeted alpha particle immunotherapy for myeloid leukemia.

  2002cited by this paper
• Actinium-225 conjugates of MAb CC49 and humanized delta CH2CC49.

  2002cited by this paper
• Polymer solutions: An introduction to physical properties

  2002cited by this paper
• The Peritoneal Microcirculation in Peritoneal Dialysis

  2001cited by this paper
• Tumor targeting using anti-her2 immunoliposomes.

  2001cited by this paper
• Tumor Therapy with Targeted Atomic Nanogenerators

  2001influential reference
• An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy.

  2001cited by this paper
• Long-lived Alpha Emitters in Radioimmunotherapy: The Mischievous Progeny

  2000cited by this paper
• Evaluation of 225Ac for Vascular Targeted Radioimmunotherapy of Lung Tumors

  2000cited by this paper
• Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

  1999cited by this paper
• Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia.

  1999cited by this paper
• Factors affecting the size distribution of liposomes produced by freeze-thaw extrusion.

  1999cited by this paper
• Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.

  1999cited by this paper
• High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.

  1999cited by this paper
• Effects of gamma irradiation on solid and lyophilised phospholipids

  1999cited by this paper
• Vascular targeted radioimmunotherapy with 213Bi-An α-particle emitter

  1998cited by this paper
• Novel applications of liposomes.

  1998cited by this paper
• Vascular targeted radioimmunotherapy with 213Bi--an alpha-particle emitter.

  1998cited by this paper
• Enhancement of the in vivo circulation lifetime of L-alpha-distearoylphosphatidylcholine liposomes: importance of liposomal aggregation versus complement opsonization.

  1997cited by this paper
• Sterically stabilized liposomes labeled with indium-111 to image focal infection.

  1995cited by this paper
• Radioimmunotherapy of Neoplastic Meningitis in Rats Using an α-Particle-emitting Immunoconjugate

  1994cited by this paper
• Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft.

  1994cited by this paper
• Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate.

  1994cited by this paper
• Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene.

  1993cited by this paper
• Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue.

  1993cited by this paper
• A model of cell inactivation by alpha-particle internal emitters.

  1993cited by this paper
• Fluorescence assay for phospholipid membrane asymmetry.

  1991cited by this paper
• The molecular mechanism of interaction between monovalent ions and polar surfaces, such as lipid bilayer membranes

  1990cited by this paper
• Radioimmunotherapy with alpha-particle-emitting immunoconjugates.

  1988cited by this paper
• Phospholipid Bilayers: Physical Principles and Models

  1987cited by this paper
• A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy.

  1987cited by this paper
• A constrained regularization method for inverting data represented by linear algebraic or integral equations

  1982cited by this paper
• Lipid polymorphism and the functional roles of lipids in biological membranes.

  1979cited by this paper
• Peritoneal Dialysis

  1948cited by this paper

• In vitro and in vivo study of 221Fr and 213Bi progeny release from the 225Ac-labelled TiO2 nanoparticles.

  2024cites this paper
• Development of 225Ac-doped biocompatible nanoparticles for targeted alpha therapy

  2024influential citation
• Automated preparation of Actinium-225 with accelerator-based production from irradiated natural thorium targets

  2024cites this paper
• Recent Innovations and Nano-Delivery of Actinium-225: A Narrative Review

  2023cites this paper
• Transport-driven engineering of liposomes for delivery of α-particle radiotherapy to solid tumors: effect on inhibition of tumor progression and onset delay of spontaneous metastases

  2021cites this paper
• Tailoring the Radionuclide Encapsulation and Surface Chemistry of La(223Ra)VO4 Nanoparticles for Targeted Alpha Therapy

  2021cites this paper
• An investigation of calcium carbonate core-shell particles for incorporation of 225Ac and sequester of daughter radionuclides: In vitro and in vivo studies.

  2021cites this paper
• Nanoparticle-based radio immune therapy in cancer care

  2021cites this paper
• Nanoradiopharmaceuticals Based on Alpha Emitters: Recent Developments for Medical Applications

  2021cites this paper
• Nanoparticles in Targeted Alpha Therapy

  2020cites this paper
• Encapsulation and retention of 225Ac, 223Ra, 227Th, and decay daughters in zircon-type gadolinium vanadate nanoparticles

  2020cites this paper
• Quantitative encapsulation and retention of 227Th and decay daughters in core-shell lanthanum phosphate nanoparticles.

  2020cites this paper
• Alpha emitting nuclides for targeted therapy.

  2020cites this paper
• Generator of Actinium-228 and a Study of the Sorption of Actinium by Carbon Nanomaterials

  2020cites this paper
• Radiolabeled liposomes and lipoproteins as lipidic nanoparticles for imaging and therapy.

  2020cites this paper
• Review of Therapeutic Applications of Radiolabeled Functional Nanomaterials

  2019cites this paper
• The in vivo fate of 225Ac daughter nuclides using polymersomes as a model carrier

  2019cites this paper
• Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine

  2019cites this paper
• Recent Research Trends on Bismuth Compounds in Cancer Chemoand Radiotherapy.

  2019cites this paper
• Development of Targeted Alpha Particle Therapy for Solid Tumors

  2019cites this paper
• Radiolabeled PET/MRI Nanoparticles for Tumor Imaging

  2019cites this paper
• Quantitative Imaging of Alpha-Emitting Therapeutic Radiopharmaceuticals

  2019cites this paper
• Radiopharmaceuticals Based on Alpha Emitters: Preparation, Properties, and Application

  2018cites this paper
• LANTHANIDE-BASED CORE-SHELL NANOPARTICLES AS MULTIFUNCTIONAL PLATFORMS FOR TARGETED RADIONUCLIDE THERAPY AND MULTIMODAL MOLECULAR IMAGING

  2018cites this paper
• Actinide Biological Inorganic Chemistry

  2018cites this paper
• Targeted and Nontargeted α-Particle Therapies.

  2018cites this paper
• Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations

  2018cites this paper
• Alpha particle spectroscopy using FNTD and SIM super‐resolution microscopy

  2018cites this paper
• Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy

  2018cites this paper
• A random walk approach to estimate the confinement of α-particle emitters in nanoparticles for targeted radionuclide therapy

  2018influential citation
• Coupling a gamma-ray detector with asymmetrical flow field flow fractionation (AF4): Application to a drug-delivery system for alpha-therapy.

  2018cites this paper
• Multifunctional GdVO4:Eu core-shell nanoparticles containing 225Ac for targeted alpha therapy and molecular imaging.

  2018cites this paper
• Multi-isotope SPECT imaging of the 225Ac decay chain: feasibility studies

  2017cites this paper
• Improved 225Ac daughter retention in InPO4 containing polymersomes.

  2017cites this paper
• Alpha-particle radiotherapy: For large solid tumors diffusion trumps targeting.

  2017cites this paper
• Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy

  2017cites this paper
• Preliminary Therapy Evaluation of 225Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from 225Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization

  2016cites this paper
• Synthesis and Applications of Alpha/Beta Emitter-Labelled Nanoparticles

  2016cites this paper
• In Vivo Radionuclide Generators for Diagnostics and Therapy

  2016cites this paper
• A review of solute encapsulating nanoparticles used as delivery systems with emphasis on branched amphipathic peptide capsules.

  2016cites this paper
• A Critical Review of Alpha Radionuclide Therapy—How to Deal with Recoiling Daughters?

  2015cites this paper
• SDF‐1 liposomes promote sustained cell proliferation in mouse diabetic wounds

  2015cites this paper
• Nanotargeted Radiopharmaceuticals for Nuclear Imaging and Radiotherapy

  2014cites this paper
• Radioisotope generators of short-lived α-emitting radionuclides promising for use in nuclear medicine

  2014cites this paper
• Anti–Prostate-Specific Membrane Antigen Liposomes Loaded with 225Ac for Potential Targeted Antivascular α-Particle Therapy of Cancer

  2014cites this paper
• Branched amphiphilic peptide capsules: cellular uptake and retention of encapsulated solutes.

  2014cites this paper
• LnPO4 Nanoparticles Doped with Ac-225 and Sequestered Daughters for Targeted Alpha Therapy

  2014cites this paper
• Retention studies of recoiling daughter nuclides of 225Ac in polymer vesicles.

  2014cites this paper
• Prospects in Folate Receptor-Targeted Radionuclide Therapy

  2013cites this paper
• Convergence of nanotechnology with radiation therapy-insights and implications for clinical translation.

  2013cites this paper
• Radionuclide Therapy of Leukemias

  2013cites this paper
• Radiometals for combined imaging and therapy.

  2013cites this paper
• Gold Coated Lanthanide Phosphate Nanoparticles for Targeted Alpha Generator Radiotherapy

  2013cites this paper
• Scope of nanotechnology-based radiation therapy and thermotherapy methods in cancer treatment.

  2012cites this paper
• An overview of targeted alpha therapy

  2012cites this paper
• Comparative In Vitro Microdosimetric Study of Murine- and Human-Derived Cancer Cells Exposed to Alpha Particles

  2012cites this paper
• Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity

  2012cites this paper
• Polymersomes as nano-carriers to retain harmful recoil nuclides in alpha radionuclide therapy: a feasibility study

  2012cites this paper
• Antitumor efficacy following the intracellular and interstitial release of liposomal doxorubicin.

  2012cites this paper
• The potential for Cerenkov luminescence imaging of alpha-emitting radionuclides

  2012cites this paper
• Chapter 22 – Targeted Radionuclide Therapy—Expanded Content

  2012cites this paper
• In vivo 212Pb/212Bi generator using indium-DTPA-tagged liposomes

  2011cites this paper
• MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy*

  2010cites this paper
• Nanotargeted Radionuclides for Cancer Nuclear Imaging and Internal Radiotherapy

  2010cites this paper
• “Smart” liposomal nanocontainers in biology and medicine

  2010cites this paper
• Multifunctional radionanomedicine: a novel nanoplatform for cancer imaging and therapy.

  2010cites this paper
• Immunoliposomal delivery of 213Bi for alpha-emitter targeting of metastatic breast cancer.

  2010cites this paper
• Novel methods of targeted drug delivery: the potential of multifunctional nanoparticles

  2009cites this paper
• Medical isotope development and supply opportunities in the 21st century

  2009cites this paper
• The use of pH-triggered leaky heterogeneities on rigid lipid bilayers to improve intracellular trafficking and therapeutic potential of targeted liposomal immunochemotherapy.

  2009cites this paper
• Cancer nanotargeted radiopharmaceuticals for tumor imaging and therapy.

  2009cites this paper
• Experimental Therapeutics , Molecular Targets , and Chemical Biology Radioimmunotherapy of Breast Cancer Metastases with α-Particle Emitter 225 Ac : Comparing Efficacy with 213 Bi and 90 Y

  2009cites this paper
• Y 90 Bi and 213 Ac : Comparing Efficacy with 225-Particle Emitter α Radioimmunotherapy of Breast Cancer Metastases with

  2009cites this paper
• Molecular imaging and therapy of cancer with radiolabeled nanoparticles.

  2009cites this paper
• Targeted High-LET Therapy of Bone Metastases

  2008cites this paper
• Targeted radionuclide therapy.

  2008cites this paper
• Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer.

  2008cites this paper
• Antibody-targeted liposomes in cancer therapy and imaging

  2008cites this paper
• THE POTENTIAL OF DRUG-CARRYING IMMUNOLIPOSOMES AS ANTICANCER AGENTS

  2008cites this paper
• Enhanced loading efficiency and retention of 225Ac in rigid liposomes for potential targeted therapy of micrometastases.

  2008cites this paper
• Radionuclide carriers for targeting of cancer

  2008cites this paper
• Enhanced Retention of the α-Particle-Emitting Daughters of Actinium-225 by Liposome Carriers

  2007cites this paper
• Targeted α-therapy: past, present, future?

  2007cites this paper
• Alpha-particle Monte Carlo simulation for microdosimetric calculations using a commercial spreadsheet

  2007cites this paper
• Targeted nanomaterials for radiotherapy.

  2007cites this paper
• Doubly radiolabeled liposomes for pretargeted radioimmunotherapy.

  2007cites this paper
• First in vivo evaluation of liposome-encapsulated 223Ra as a potential alpha-particle-emitting cancer therapeutic agent.

  2006cites this paper
• The average number of alpha-particle hits to the cell nucleus required to eradicate a tumour cell population

  2006cites this paper
• Liposomes as targeted drug delivery systems in the treatment of breast cancer

  2006cites this paper
• Lanthanide-Loaded Liposomes for Multimodality Imaging and Therapy

  2006cites this paper
• Systemic targeted radionuclide therapy: potential new areas.

  2006cites this paper
• High-Activity Radio-Iodine Labeling of Conventional and Stealth Liposomes

  2006cites this paper
• Assessing the 210At impurity in the production of 211At for radiotherapy by 210Po analysis via isotope dilution alpha spectrometry.

  2006cites this paper
• Etude de faisabilité du radiomarquage et du préciblage de liposomes pour la radioimmunothérapie

  2005cites this paper
• Liposome-mediated radiotherapeutics within avascular tumor spheroids: comparative dosimetry study for various radionuclides, liposome systems, and a targeting antibody.

  2005cites this paper
• 29 Metal complexes as pharmaceuticals

  2005cites this paper
• Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs.

  2004cites this paper
• Therapy of Ovarian Carcinoma by Targeted Delivery of Alpha-Particles Using Immunoliposomes Capable of Retaining Alpha-Emitting Daughters

  2004cites this paper